Stockscreener 앱 받기
10.20
4.32%
-0.46
시간 외 거래:
10.40
0.20
+1.96%
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
Suvretta Capital Management's Strategic Acquisition in Benitec B - GuruFocus.com
How To Trade (BNTC) - Stock Traders Daily
Simplify Asset Management Inc. Increases Position in Benitec Biopharma Inc. (NASDAQ:BNTC) - MarketBeat
Benitec Biopharma Inc reports results for the quarter ended September 30Earnings Summary - XM
Benitec Biopharma Inc. (BNTC) Quarterly 10-Q Report - Quartz
Benitec Biopharma executives receive performance bonuses - Investing.com
Analysis of JANUS HENDERSON GROUP PLC's Recent Transaction in Be - GuruFocus.com
Benitec Biopharma Awards Bonuses to Key Executives - TipRanks
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update - The Manila Times
Benitec's BB-301 Shows Major Clinical Gains: 35-40% OPMD Symptom Improvement | BNTC Stock News - StockTitan
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Update - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $22.60 Average Target Price from Analysts - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Average Recommendation of “Buy” from Analysts - Defense World
(BNTC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewswire
Long Term Trading Analysis for (BNTC) - Stock Traders Daily
Piper Sandler Initiates Coverage of Benitec Biopharma (BNTC) with Overweight Recommendation - MSN
Janus Henderson Group PLC Expands Investment in Benitec Biopharm - GuruFocus.com
Janus Henderson Group PLC Expands Investment in Benitec Biopharma Inc - Yahoo Finance
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $19.50 Average Price Target from Analysts - Defense World
Benitec Biopharma: OPMD Program Continues To Advance With Catalysts (NASDAQ:BNTC) - Seeking Alpha
Q1 Earnings Estimate for BNTC Issued By Leerink Partnrs - MarketBeat
Benitec started at outperform by Oppenheimer on gene therapy potential (NASDAQ:BNTC) - Seeking Alpha
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $19.50 Average Target Price from Analysts - MarketBeat
Oppenheimer Begins Coverage on Benitec Biopharma (NASDAQ:BNTC) - MarketBeat
JMP Securities Increases Benitec Biopharma (NASDAQ:BNTC) Price Target to $18.00 - Defense World
Benitec Biopharma Reports Promising Results for BB-301 Trial - TipRanks
Benitec Biopharma’s Oculopharyngeal Muscular Dystrophy Gene Therapy Produces Clinical Improvements in Swallowing in Phase 1b/2a Trial - CGTLive™
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
Gene Silencing Market to Expand with Significant CAGR by 2034 |Alnylam Pharmaceuticals, Benitec Biopharma, Arrowhead Pha – IndiaPolitics.com - IndiaPolitics.com
JMP Securities Raises Benitec Biopharma (NASDAQ:BNTC) Price Target to $18.00 - MarketBeat
Piper Sandler maintains Overweight rating on Benitec BioPharma stock By Investing.com - Investing.com UK
Leerink reiterates Benitec BioPharma at Outperform following new BB-301 data - Investing.com Canada
Benitec Biopharma Announces Updated Investor Webcast Information - GlobeNewswire
Global Antisense & RNAi Therapeutics Market Growth in Future - openPR
Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase - The Bakersfield Californian
Benitec Biopharma Reports Positive Data from Two Subjects - GlobeNewswire
Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society - StockTitan
Costco Wholesale (COST-Q) QuotePress Release - The Globe and Mail
Coinbase Global Inc Cl A (COIN-Q) QuotePress Release - The Globe and Mail
RNAi Therapeutics Market Focusing on Trends and Innovations - openPR
Benitec Biopharma (NASDAQ:BNTC) Stock Price Crosses Above Fifty Day Moving AverageShould You Sell? - MarketBeat
Benitec Biopharma's BB-301: Potential In OPMD, But Still Too Early Stages (NASDAQ:BNTC) - Seeking Alpha
Benitec Biopharma Inc. Reports on Recent Stockholder Activity - MarketBeat
Benitec Biopharma issues shares after warrant exercises By Investing.com - Investing.com South Africa
Benitec Biopharma issues shares after warrant exercises - Investing.com India
5 Top NASDAQ Biotech Stocks of 2024 - Nasdaq
When the Price of (BNTC) Talks, People Listen - Stock Traders Daily
Fresh Study Reveals the Duchenne Muscular Dystrophy Market Insights, Demand, and Forecast to 2033 - WhaTech
Benitec Biopharma Stock (BNTC) Surges on Potentially Groundbreaking OPMD Treatment - Nasdaq
Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth - Simply Wall St
Benitec Biopharma stock soars to 52-week high of $10.9 By Investing.com - Investing.com South Africa
0.93%
3.55%
자본화:
|
볼륨(24시간):